LARGE (xylosyl- and glucuronyltransferase 1) activators are a class of molecules that stimulate the activity of the LARGE enzyme. The LARGE enzyme, also known as LARGE1 or like-glycosyltransferase, is an endoplasmic reticulum-resident type II transmembrane protein. This protein has dual glycosyltransferase functions and it synthesizes a unique O-mannosyl-linked glycan during biosynthesis, which is an essential process in cellular function. The role of LARGE activators is to enhance the function of this enzyme, thereby increasing the production of crucial glycans within cells. Glycans, complex carbohydrates that are covalently linked to other biological molecules, play vital roles in many biological processes. They are involved in cell-cell interactions, immune response, pathogen recognition, and protein folding, among other things.
LARGE activators work by binding to the LARGE enzyme and increasing its activity. The specific mechanism by which these activators interact with the enzyme is dependent on the activator's chemical structure. These chemical agents can interact directly with the active site of the enzyme or bind to allosteric sites, modulating the enzyme's conformation and thus its activity. It's important to note that the specificity and selectivity of these activators are key parameters that influence their efficiency and effectiveness. The development of LARGE activators involves understanding the structure and function of the LARGE enzyme, the nature of the glycan substrates it acts on, and the particular conditions under which the enzyme functions optimally. Thus, LARGE activators represent a unique category of chemical agents that modulate a critical aspect of cellular biochemistry.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Manganese | 7439-96-5 | sc-250292 | 100 g | $270.00 | ||
A trace metal that serves as a co-factor for many glycosyltransferases, potentially enhancing their activity, which can indirectly increase the activity of LARGE1. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cell-permeable cAMP analog. By acting as a secondary messenger, it could influence intracellular signaling pathways to indirectly increase LARGE1-mediated glycosylation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
A plant-derived compound that stimulates the production of cAMP. Increased cAMP can potentially enhance protein glycosylation indirectly through LARGE1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A phorbol ester that activates protein kinase C (PKC). PKC activation can potentially influence intracellular signaling pathways to indirectly enhance LARGE1 function. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
A hormone that stimulates various cellular processes. By enhancing general intracellular activity, it may indirectly increase LARGE1-mediated glycosylation. | ||||||
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $38.00 $198.00 $65.00 | 5 | |
A monosaccharide that can increase protein glycosylation in cells. By enhancing overall glycosylation, it could indirectly promote LARGE1 activity. | ||||||
D-Galactose | 59-23-4 | sc-202564 | 100 g | $288.00 | 4 | |
A monosaccharide that can be converted to UDP-galactose in cells. By increasing the availability of this glycosylation substrate, it could indirectly enhance LARGE1 activity. | ||||||
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $201.00 $779.00 | ||
An amino sugar that can enter the hexosamine biosynthetic pathway and potentially enhance glycosylation. By enhancing overall glycosylation, it could indirectly promote LARGE1 activity. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
An antibiotic that inhibits N-linked glycosylation, but could potentially redirect cellular resources to enhance O-linked glycosylation, indirectly enhancing LARGE1 activity. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
A statin that has been reported to increase glycosylation of some proteins. By enhancing overall glycosylation, it could indirectly stimulate LARGE1 activity. | ||||||